Postoperative adjuvant radiotherapy in breast cancer patients. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor Axilla Lymph Nodes Neoplastic Cells, Circulating Thoracic Wall Tumor Cells, Cultured MCF-7 Cells Mammary Glands, Human Organs at Risk Nipples Neoplastic Stem Cells

Organisms2

Mice, Nude Mice, Inbred BALB C

Diseases57

Breast Neoplasms Neoplasm Recurrence, Local Lymphatic Metastasis Carcinoma, Ductal, Breast Rectal Neoplasms Adenocarcinoma Neoplasm Metastasis Lung Neoplasms Neoplasm Invasiveness Radiation Injuries Carcinoma, Intraductal, Noninfiltrating Neoplasms Radiodermatitis Breast Neoplasms, Male Stomach Neoplasms Breast Diseases Carcinoma, Lobular Neoplasms, Second Primary Carcinoma Carcinoma, Squamous Cell Head and Neck Neoplasms Endometrial Neoplasms Neoplastic Cells, Circulating Bone Neoplasms Prostatic Neoplasms Seminoma Ependymoma Neoplasms, Hormone-Dependent Disease Progression Brain Neoplasms Sarcoma Ovarian Neoplasms Genetic Predisposition to Disease Spinal Cord Neoplasms Thymoma Thymus Neoplasms Carcinoma, Ductal Mammary Neoplasms, Experimental Recurrence Testicular Neoplasms Soft Tissue Neoplasms Colonic Neoplasms Colorectal Neoplasms Carcinoma, Non-Small-Cell Lung Fibrocystic Breast Disease Fatigue Uterine Cervical Neoplasms Pancreatic Neoplasms Carcinoma in Situ Neoplasms, Radiation-Induced Triple Negative Breast Neoplasms Bone Marrow Neoplasms Neovascularization, Pathologic Neoplasms, Multiple Primary Fibroadenoma Lymphedema Nasopharyngeal Neoplasms

Chemicals and Drugs60

Fluorouracil Receptors, Estrogen Tamoxifen Receptor, erbB-2 Tegafur Tumor Markers, Biological Antineoplastic Agents, Hormonal Receptors, Progesterone Antineoplastic Agents Adjuvants, Immunologic Cisplatin Antimetabolites, Antineoplastic Cyclophosphamide Epirubicin Uracil Aromatase Inhibitors Neoplasm Proteins Doxorubicin Leucovorin Petrolatum Anthracyclines Freund's Adjuvant Antibodies, Monoclonal, Humanized Estrogen Antagonists BRCA2 Protein Estrogen Receptor alpha BRCA1 Protein Estrogens DNA, Neoplasm Paclitaxel RNA, Messenger Nitriles Antigens, Neoplasm Mucin-1 Antibodies, Monoclonal Methotrexate Taxoids Estrogen Receptor Modulators Bleomycin Triazoles Tumor Suppressor Protein p53 Ki-67 Antigen Selective Estrogen Receptor Modulators Cancer Vaccines Estradiol Receptor, Epidermal Growth Factor Antibiotics, Antineoplastic Mammaglobin A Vinblastine Adjuvants, Pharmaceutic Deoxycytidine Keratin-19 Antineoplastic Agents, Phytogenic RNA, Small Interfering Carcinoembryonic Antigen Tumor Suppressor Proteins Antineoplastic Agents, Alkylating Keratins Radiopharmaceuticals RNA, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment88

Radiotherapy, Adjuvant Chemotherapy, Adjuvant Radiotherapy Neoplasm Staging Combined Modality Therapy Prognosis Disease-Free Survival Radiotherapy Dosage Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Survival Analysis Survival Rate Follow-Up Studies Mastectomy, Segmental Retrospective Studies Mastectomy Lymph Node Excision Radiotherapy, Conformal Radiotherapy, High-Energy Prospective Studies Postoperative Care Risk Factors Radiotherapy, Intensity-Modulated Kaplan-Meier Estimate Radiotherapy Planning, Computer-Assisted Multivariate Analysis Drug Administration Schedule SEER Program Mammography Immunohistochemistry Case-Control Studies Postoperative Period Proportional Hazards Models Neoadjuvant Therapy Cohort Studies Dose Fractionation Gastrectomy Early Detection of Cancer Gene Expression Profiling Sentinel Lymph Node Biopsy Laryngectomy Predictive Value of Tests Radiotherapy, Image-Guided Reverse Transcriptase Polymerase Chain Reaction Risk Assessment Risk Radiotherapy, Computer-Assisted Sensitivity and Specificity Neoplasm Grading Randomized Controlled Trials as Topic Incidence Prostatectomy Tumor Burden Mammary Neoplasms, Experimental Mastectomy, Modified Radical Odds Ratio Tomography, X-Ray Computed Clinical Trials as Topic Dose-Response Relationship, Radiation Breast Self-Examination Reproducibility of Results Registries Questionnaires Xenograft Model Antitumor Assays Mastectomy, Radical Blotting, Western Tissue Array Analysis Oligonucleotide Array Sequence Analysis Immunoenzyme Techniques Mammaplasty Brachytherapy Neoplasm Transplantation Polymerase Chain Reaction Logistic Models Pilot Projects Ultrasonography, Mammary Palliative Care Feasibility Studies Chemoradiotherapy Radiosurgery Transplantation, Heterologous In Situ Hybridization, Fluorescence Confidence Intervals Biopsy, Needle Biopsy Radiation Dosage Enzyme-Linked Immunosorbent Assay Analysis of Variance

Psychiatry and Psychology2

Breast Self-Examination Breast Feeding

Phenomena and Processes33

Gene Expression Regulation, Neoplastic Time Factors Postmenopause Premenopause Genes, BRCA1 Drug Resistance, Neoplasm Menopause Genetic Predisposition to Disease Genes, erbB-2 Risk Sensitivity and Specificity Cell Proliferation Genes, BRCA2 Odds Ratio Radiation Tolerance Dose-Response Relationship, Radiation Mutation Germ-Line Mutation Genotype Breast Feeding Polymorphism, Genetic Dose-Response Relationship, Drug Apoptosis Signal Transduction Gene Amplification DNA Methylation Cell Movement Cell Division Genes, p53 Radiation Dosage Down-Regulation Promoter Regions, Genetic Up-Regulation

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Radiation Oncology

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science9

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted SEER Program Radiotherapy, Computer-Assisted Incidence Registries Questionnaires

Named Groups1

Health Care37

Disease-Free Survival Treatment Outcome Survival Analysis Survival Rate Follow-Up Studies Retrospective Studies Prospective Studies Radiation Injuries Postoperative Care Risk Factors Kaplan-Meier Estimate Multivariate Analysis SEER Program Case-Control Studies Postoperative Period Proportional Hazards Models Cohort Studies Age Factors Predictive Value of Tests Risk Assessment Risk Sensitivity and Specificity Randomized Controlled Trials as Topic Incidence Odds Ratio Clinical Trials as Topic Dose-Response Relationship, Radiation Reproducibility of Results Registries Questionnaires Logistic Models Pilot Projects Palliative Care Feasibility Studies Confidence Intervals Radiation Dosage Analysis of Variance

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Radiotherapy, Adjuvant Chemotherapy, Adjuvant Breast Neoplasms Radiotherapy Neoplasm Staging Combined Modality Therapy Neoplasm Recurrence, Local Breast Prognosis Disease-Free Survival Radiotherapy Dosage Treatment Outcome Antineoplastic Combined Chemotherapy Protocols Survival Analysis Survival Rate Lymphatic Metastasis Follow-Up Studies Fluorouracil Mastectomy, Segmental Carcinoma, Ductal, Breast Retrospective Studies Mastectomy Rectal Neoplasms Receptors, Estrogen Tamoxifen Receptor, erbB-2 Adenocarcinoma Neoplasm Metastasis Tegafur Tumor Markers, Biological Lymph Node Excision Radiotherapy, Conformal Antineoplastic Agents, Hormonal Receptors, Progesterone Radiotherapy, High-Energy Antineoplastic Agents Lung Neoplasms Adjuvants, Immunologic Cell Line, Tumor Prospective Studies Neoplasm Invasiveness Radiation Injuries Carcinoma, Intraductal, Noninfiltrating Gene Expression Regulation, Neoplastic Neoplasms Cisplatin Antimetabolites, Antineoplastic Postoperative Care Radiodermatitis Risk Factors Breast Neoplasms, Male Stomach Neoplasms Breast Diseases Axilla Radiotherapy, Intensity-Modulated Kaplan-Meier Estimate Radiotherapy Planning, Computer-Assisted Time Factors Multivariate Analysis Carcinoma, Lobular Drug Administration Schedule Cyclophosphamide Neoplasms, Second Primary Epirubicin SEER Program Mammography Carcinoma Immunohistochemistry Postmenopause Carcinoma, Squamous Cell Uracil Aromatase Inhibitors Neoplasm Proteins Doxorubicin Head and Neck Neoplasms Case-Control Studies Postoperative Period Proportional Hazards Models Leucovorin Premenopause Neoadjuvant Therapy Cohort Studies Dose Fractionation Lymph Nodes Gastrectomy Genes, BRCA1 Endometrial Neoplasms Neoplastic Cells, Circulating Bone Neoplasms Drug Resistance, Neoplasm Prostatic Neoplasms Seminoma Ependymoma Petrolatum Menopause Neoplasms, Hormone-Dependent Disease Progression Brain Neoplasms Sarcoma Early Detection of Cancer

No FAQ available that match "postoperative adjuvant radiotherapy in breast cancer patients"